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ABSTRACT 
 
Introduction: Acute lymphoblastic leukemia (ALL) is the most common leukemia 
subtypes among paediatrics in Malaysia. Although treatment options are available but 
some patients remain incurable, some undergo relapse and many experiences adverse 
effects by the conventional therapies. Thus, we aim to investigate possible treatment 
alternative by studying the antileukemogenesis properties of concentrated Nypa fruticans 
sap called nisaan by focusing on adiponectin expression.  
 
Method: Our study model was CCRF-CEM, an acute lymphoblastic leukemia cell lines. 
The cells were treated with nisaan at a range of concentration and treated for 24, 48 and 
72 hours followed by determination of the leukemic cells viability using tryphan blue 
method. Effective nisaan concentrations that significantly reduced the cells viability were 
again treated to the cells followed by determination of the cell proliferation using BrdU 
colorimetric kit and adiponectin level using adiponectin ELISA kit.  
 
Results: The results showed that, increase concentration of nisaan treatment reduced the 
cells viability and cells proliferation and enhance the adiponectin level in the leukemic 
cells.  
Conclusion: This preliminary data suggest that Nypa fruticans might has the anti-
leukemogenesis effect on acute lymphoblastic cells by regulating the adiponectin 
expression. 
 
KEY WORDS: Nypa fruticans, adiponectin, acute lymphoblastic leukemia, cells cytotoxicity 
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INTRODUCTION 
 
Adiponectin is a hormone secreted by the adipocytes. It involved in metabolic pathways 
regulation by down-regulates genes that involved in gluconeogenesis pathway (Berg, et 
al., 2001), the uptake of glucose, the fatty acid metabolism and also lactate synthesis in 
myocytes (Yamauchi, et al., 2002). Decreased plasma adiponectin level was shown to lead 
to insulin resistance in type 2 diabetes (Kubota, et al., 2002) and atherosclerosis (Okamoto, 
et al., 2002). Apart from metabolic diseases, adiponectin may also involve in the 
pathogenesis pathway of several type of cancers. Previous studies had shown 
adiponectin had antiproliferative effect on breast cancer cells in vitro by activating the 
adiponectin receptors (Körner, et al., 2007). Apart from the breast cancer cell lines 
(Takahata et al. 2006), the receptors were shown to be expressed in prostate cell lines 
(Mistry, et al., 2006) and hepatocellular (Miyazaki, et al., 2005) carcinoma cell lines. In 
addition, the expression of adiponectin receptors, AdipoR1/R2 was shown to be 
inversely correlated with plasma insulin concentrations and decrease in pathologic 
conditions (Tsuchida, et al., 2004). 
 
Leukemia is a group of heterogenous disease of the bone marrow due that lead to 
formation of unusually high numbers of immature blood cells called blasts. The blast cells 
are able to proliferate uncontrollably but lack the functions of normal blood cells. 
Overcrowding of the bone marrow with the leukemic cells lead to less production of 
normal blood cells including platelet to carry out normal physiological functions. Further, 
the leukemic cells also able to metastase to other part of the body such as lymph nodes, 
kidneys, adrenals and the heart (Trendowski, 2014).  
 
This group of disease is a health concern globally. In 2010, approximately 281,500 people 
died due to leukemia (Lozano, et al., 2012). Leukemia is also a major concern in Malaysia. 
ALL is the major subtypes among Malaysian pediatrics (MASPHO, 2009) and many 
patients experience remission after undergoing the conventional therapy (Conter, et al., 
2010). The exact cause of leukemia is unknown. Factors involved could be inherited or 
could be environmental (non-inherited).  
 
Most forms of leukemia are treated with a multi-drug chemotherapy regimen, others 
with radiation therapy or BM transplant (NCI). Prognosis and response towards therapy 
varies in patients. Some patients are cured, others might not and some undergo 
remission. Moreover, many patients experience side effects such as loss of hair, loss of 
appetite, fatigue and also damage the blood-producing cells in bone marrow due to the 
conventional therapy. The success of treatment depends on the type of leukemia and 
other factors. Thus, lots of studies are undergoing to better understand and eventually 
find effective alternative in treating the disease. 
 
One possible alternative with fewer side effects could lies in the herbal medicine or 
possibly components from natural resources that might possess the medicinal properties. 
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The usage of herbal medicine to treat diseases could be traced back to 5000 years ago by 
the Sumerian and in many culture, herbal remedies were used to treat many diseases. 
Nowadays, advancement in herbal medicine researches had led to the development of 
pharmaceutical agents derived from natural resources such as plants, animals, marine 
organisms and also microorganisms. Vincristine for example, is a plant-derived 
compound and is used to treat cancer (Guérritte, et al., 2005). 
 
Malaysia is rich with natural resources that promote the interests and advances in 
medicinal plant research. Many had shown promising effect towards certain type of 
diseases and had led to discovery of biologically active compounds to be used as chemical 
templates to produce new drug candidates (Jantan, 2004). Nypa fruticans or locally known 
as nipah palm is one of the species of palm native to the coastlines and estuarine habitats  
that were claimed by the natives to have several medicinal properties but lacking in 
scientific data to prove the claim. The palm produces fruit with edible endosperm (Teo, 
et al., 2010). The flower cluster or inflorescence can be tapped before it blooms to yield 
edible sap and collected as local alcoholic beverage called tuak or nira. Nira could be 
stored to produce a type of vinegar called nipah vinegar. The nira is boiled to make it into 
concentrate to yield nisaan which is used in many traditional dishes. 
 
The local claimed that nira and vinegar able to treat many conditions such as diabetes, 
high blood pressure, gout and kidney stone (Mat Satar, et al., 2011). Preliminary scientific 
studies had shown that methanolic extract of leaf and stem of nipah had antiglycemic 
properties based on a study conducted on glucose loaded hyperglycemic mice (Reza, et 
al., 2011). A preliminary study had indicated that the methanol extract of nipah fruit to 
be cytotoxic against MCF-7, the breast cancer cells (Nurul Huda, et al., 2011).  
 
To date, there are limited scientific studies to further support the local claims on this 
important underutilized fruit notably in cancer. Therefore, we aim to screen for possible 
antileukemogenesis properties of nipah palm produce which is nisaan and its possible 
involvement in adiponectin expression. 
 
METHOD 
 
Maintaining the culture 
 
The acute lymphoblastic cell line, CCRF-CEM cells (purchased from ATCC) were 
cultured in RPMI supplemented with 10% FBS and 0.1mg/ml penicillin and 
streptomycin. The cultures were maintained at 37oC in a humidified incubator with 5% 
CO2.  
 
Sample 
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The nisaan was concentrated product from nipah sap. It was provided by a local from 
Pulau Gajah, Kelantan who collected the nipah sap from around the area. The sap was 
then heated to make it in a concentrated form and this step produced the syrup. The 
syrup was dried in an oven for 2 weeks and weighed several times during the drying 
process to achieve the constant weight. 
 
Sample Preparation 
 
The nisaan was weighted and directly diluted in complete culture medium to prepare the 
working concentrations. 
 
Cell Viability Assay 
 
Screening for effective nisaan concentrations towards the CCRF-CEM cells was done by 
tryphan blue exclusion assay according to protocols described previously (Strober , 2001). 
Briefly, the cells were treated with five nisaan concentration i.e 0, 3.125,6.25,12.5,25 & 50 
mg/mL for 24, 48 and 72 hours. Then, the cells were mixed with the dye and visually 
examined. Viable cells were able to exclude the dye and appear bright under the inverted 
microscope while non-viable cells took up the dye and stained blue. Then, the percentage 
of viable cells was calculated. 
 
BrdU Cell Proliferation ELISA Kit (Abcam) 
 
The method was employed to confirm the cells viability and proliferation. Two nisaan 
concentrations that significantly affected the cells viability were used to treat the CCRF-
CEM cells and cells without treatment were used as control. After 24 hours, the cells 
proliferation rate was determined using BrDu. Bromodeoxyuridine (5-bromo-2-
deoxyuridine, BrdU) was a synthetic analog of the nucleoside thymidine. The compound 
was incorporated into replicating DNA in dividing cells, thus labelled the in vitro 
dividing cells. Anti-BrdU antibodies were added and visualized with HRP conjugated 
secondary antibodies and DAB.  
 
Determination of Adiponectin Level 
 
Adiponectin expression after treatment with nisaan was determined by ELISA method 
using the adiponectin Assay kit (Adipogen). The cells were treated with effective nisaan 
concentration (12.5 mg/ml, 6.25 mg/ml and 3.125 mg/ml ) with non-treated cells as 
control for 24 hours. Then, the cells were collected and lysed using a 1% Triton in PBS in 
a 21-mm gauge needle. The ELISA assays were carried out according to the manufacturer 
protocols. 
 
Statistical Analysis 
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The data were analyzed by non-parametric test Kruskal-Wallis using SPSS software and 
p value less than 0.05 was taken as statistically significant. 
 
RESULTS 
 
Nypa fruticans syrup extract was screened for its effect on viability of the CCRF-CEM 
acute lymphoblastic leukemic cell line at concentrations of 25 mg/ml, 50 mg/ml, 100 
mg/ml, 200 mg/ml and 400 mg/ml for three different incubation times of 24 hours, 48 
hours and 72 hours (figure 1). The lowest nisaan dosage, 25 mg/ml reduced 10 % of the 
cell viability and it was significantly lower compared to control group. The cell viability 
was found as 84.8%, 68.4% and 66.8%, respectively. Similar trend was shown for 48 and 
72 hours of treatment. To confirm the cells toxicity, cell proliferation assays using BrDU 
was conducted. Treatment with 3.13 mg/ml and 12.5 mg/ml cells showed significant 
reduction in cells proliferation compared to control (figure 2). As for adiponectin assays, 
the results showed that adiponectin expression in both treatment groups were 
significantly higher than the control group (figure 3). This result was inversely correlated 
to the cells toxicity study. 
 
 
 
 
 
 
Figure 1 The figure shows the percentage of CCRF-CEM cells viability after being treated 
with 5 different nisaan concentrations at 24, 48 and 72 hours (n =3).  All treated groups showed 
significant viability reduction compared to control (p<0.05). The treatment also showed 
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significantly reduced cells viability in a dose-dependent manner. Similar pattern was shown in 
the three different incubation times. 
 
 
 
Figure 2 The figure showes the rate of CCRF-CEM cells proliferation after treatment with 
selected nisaan concentrations at 24 hours (n=3).  * refer to p < 0.05 compared to control group. 
Two lowest concentrations of nisaan that significantly reduced the leukemic cells viability were 
treated at 24 hours and these concentration were also shown to significantly reduce the cells 
proliferation using BrDU assay.  
 
 
Figure 3 CCRF-CEM cells adiponectin expression after treated with nisaan at selected 
concentrations. * refer to p < 0.05 compared to control group. Treatment with nissaan significantly 
increased adiponectin level in the CCRF-CEM cells in a dose-dependent manner.  
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DISCUSSION 
 
Previous studies on nipah showed that it had antimicrobial activities against Vibrio 
alginolyticus (Shamsuddin, et al., 2013). The midveins,  husks and leaves extracts of this 
plant were shown for to have antimicrobial property against Klebsiella pneumonia, 
Pseudomonas aeruginosa, Escherichia coli, Staphylococcus epidermidis and Staphylococcus 
aureus (Ebana, et al., 2015). More studies had shown that nipah extract had 
antihyperglycemic activities. Methanolic extract from the leaf and stem of nipah were also 
shown to possess anti-hyperglycemic activity on glucose loaded hyperglycemic and  
antinociceptive activity on mice model (Reza, et al., 2011). Furthermore, food product 
from nipah called nipah vinegar possesses antihyperglycaemic activities comparable to the 
metformin in rat model. The findings also suggest that antioxidant compounds of the 
vinegar do not contribute much towards the overall observed antidiabetic effect (Yusoff, 
et al., 2015). In addition, nipah vinegar was shown to be able to suppress postprandial 
hyperglycemia following glucose, sucrose and starch load (Yusoff, et al., 2015).  
 
Very limited studies were conducted to investigate the possible anticancer 
properties of nipah. Recent study showed that the methanol extract of nipah showed 
cytotoxicity activity against breast cancer cell lines, MCF-7 (Nurul Huda, et al. 2011). In 
this study, we had showed that nipah also showed cytotoxicity activity against the acute 
lymphoblastic leukemia cell lines, CCRF-CEM. To further understand the possible 
mechanism involved, we had also investigate the level of adiponectin expressed in the 
cells upon treatment with nipah and found that the leukemic cells viability decrease upon 
treatment but on the other hand, showed increment of adiponectin expression. 
 
Previous study had characterized the phytochemical content of nipah fruits extract. 
Chlorogenic acid was identified as major compound in the extract. Unripe endosperm 
extract of nipah fruits showed high antioxidant capacities, total flavonoid and total 
phenolics, content as compared to ripe endosperm extract (Prasad, et al., 2013) and might 
play a major role in pathological conditions related with free-radical generated disease.  
 
Chlorogenic acid, the major compound in nipah extract might also be the 
phytochemical responsible in contributing to its medicinal properties. Chloregenic acid 
is a phenolic acid present in many types of fruits, vegetable and seeds. Previous study 
had shown that chlorogenic acid decreased fasting plasma glucose and HbA1c level in 
diabetes and also improve kidney fibrosis possibly by modulating the adiponectin 
receptor signaling pathways in diabetic mice model (Jin, et al., 2015).  Furthermore, 
studies had also shown that consumption of coffee rich in chlorogenic acid decrease 
plasma glucose (van Dijk, et al., 2009, Johnston, et al., 2003, Olthof, et al., 2011), reduce 
weight loss in obese people (Thom, 2007), lower plasma glucose and C-reactive protein 
levels and also improve liver function in diabetic patients (Herrera-Arellano, et al., 2004, 
Abidov, et al., 2006).  
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Furthermore, this compound was shown to have antidiabetic properties in animal 
models (Karthikesan, et al., 2010, Rodriguez & Hadley, 2002, Zhang, et al., 2011, Li, et al., 
2009). Another study showed that chlorogenic acid significantly reduced FPG and 
HbA1c, accompanied by increased adiponectin level in adipose tissues of type 2 diabetic 
mouse model. Their data also indicated that the increased of adiponectin receptors, 
ADPNR-2 in the liver and muscle of the animal models (Jin, et al., 2015). ADPNR-2 is 
involved in the activation of adiponectin signaling pathway and reduction of the receptor 
expression lead to reduce adiponectin sensitivity and this function relies on adiponectin 
(Yamauchi & Kadowaki, 2008 , Peters, et al., 2013, Yamauchi, et al., 2007). 
 
Adiponectin was also showed to be the inhibitor that capable to prevent cancer 
progression and invasion via their receptors. Evidences from previous studies showed 
that the level of plasma adiponectin was inversely associated with the risk of cancer 
development correlated with the obesity body weight index (BMI) status and insulin 
resistance including  endometrial cancer, breast  cancer, prostate, colon and gastric cancer 
and also leukemia (Shehzad, et al., 2012). 
 
In determining the association of adiponectin in progression of cancer specifically 
for leukemia or blood diseases, the level of adiponectin and presence of adiponectin’s 
receptors could be a significant indicator of the state of diseases. In leukemia, lymphomas 
or myeloproliferative diseases, studies have observed the disturbances of the level of 
circulating adiponectin due to these diseases (Bastard & Fève, 2012). Furthermore, in 
study reported by Ozturk et al. (2012), the levels of serum adiponectin were inversely 
associated with the types of childhood leukemia including childhood acute myeloblastic 
leukemia (AML). Moreover, it has been found that, the circulating levels of adiponectin 
were lower for both chronic lymphoproliferative and myeloproliferative diseases. The 
study also suggested that adiponectin could promote the migratory characteristic in 
cancer cells by which contributing to their ability to spread.  
 
Based on study by Lang & Ratke (2009), despite the fact that adiponectin 
exclusively secreted by adipocytes, this protein able to work on tumor cells directly for 
various cancer cells which express AdipoR1 and adipoR2 receptors. This finding is 
supported with studies of Dalamaga & Koumaki (2014) which stated that, expression of 
adiponectin receptors have been found on various cancer cell lines by which suggested 
that the adiponectin able to exert direct actions on these cells. Besides, based from 
Grossman & Clearly (2012), also stated that in chronic stages of disease where the cancers 
invade aggressively, the lack of adiponectin able to build a compensatory mechanism 
and a complicated counter play among adiponectin and cellular environment that might 
influence the metastasize of tumor. 
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CONCLUSION 
 
Based on our results, treatment of the ALL cells with nipah lead to increase cells 
cytotoxicity followed by increment of adiponectin level. We postulate that chlorogenic 
acid, which is the major compound found in nipah might increase the cells cytotoxicity 
through adiponectin signaling pathway by up-regulating the adiponectin receptor. 
Further study needed to be done to validate the hypotheses. 
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